Abstract:Background and Objectives: Hematological disorders, especially chronic anemia and coagulation disorders, are common in patients with chronic kidney disease (CKD). Severe anemia is associated with increased cardiovascular morbidity and mortality in this special group of patients and is also responsible for decreased hope and quality of life. Despite the use of appropriate iron therapy and erythropoietin-stimulating agents, red blood cell transfusion is occasionally required, usually in the setting of acute bleeding or for correction of perioperative anemia. The COVID-19 pandemic has accelerated the progression of chronic diseases and worsened the outcomes for patients with nephrological conditions. As a precautionary measure against infections, patients' access to hospitalization for their procedures has been reduced and their chronic complications, including hematological abnormalities, have gotten out of control. Materials and Methods: Our retrospective observational study was designed to evaluate the impact of the COVID-19 pandemic on blood transfusion for the patients with chronic kidney disease hospitalized in our emergency county medical unit, over a period of four years (2019-2022) who were admitted or at least referred for evaluation to the Nephrology department. We also followed the measures adopted to ensure the necessary blood products during this time. Results: Between 2190-2022, a total of 24,096 hospitalized patients were transfused at the Emergency County Clinical Hospital in Constanta, Romania. Meanwhile, in the nephrology and other medical or surgical wards of our medical unit, 1590 CKD patients were transfused with different blood derivatives. During the pandemic years, as expected, the number of transfused patients and transfused blood units decreased by 4% and 7%, respectively, in comparison with the pre-pandemic year, 2019. Unlike the general trend of transfusion activity, more patients with CKD transfused in 2022 (580) than before the pandemic (414 in 2019), and the number of blood units was higher in 2022 than in 2019 for red blood products and plasma. Between 2020-2022, from the total number of transfused patients in our study, 254 with CKD patients (16%) and 798 non-CKD (4%) died in-hospital. Conclusions: The adaptive strategies implemented to ensure the necessary blood products in the hospital during the COVID-19 pandemic mainly included restrictive transfusion and limitation of elective surgical procedures. The subject matter of the article is important as blood shortages are a problem that healthcare workers may encounter in future pandemics.

Discussion on the Safety of Blood Products During the COVID-19 Pandemic

Analysis on Emergency Authorization Policies of Medical Products

An international comparison analysis of reserve and supply system for emergency medical supplies between China, the United States, Australia, and Canada

The Impact of Emerging Infectious Diseases on Chinese Blood Safety

Discussions on the Emergency Medical Procedure of Children′s Hospitals Against COVID-19 Epidemic

Transfusion safety concerns during the COVID-19 pandemic in Taiwan: Altered by evolving control strategies

Prevention and Consideration for the Biosafety of Laboratory Testing under Epidemic Condition

Retraction Note To: Methylene Blue Photochemical Treatment As a Reliable SARS-CoV-2 Plasma Virus Inactivation Method for Blood Safety and Convalescent Plasma Therapy for COVID-19

Covid‐19 pandemic‐ response to challenges by blood transfusion services in India: a review report

Changes in the medical-seeking pattern and daily behavior of hematopoietic stem-cell transplant recipients during the COVID-19 epidemic: An online survey in Hubei Province, China

An Interim Review of Lessons from the Novel Coronavirus (Sars-Cov-2) Outbreak in China

A Two-Objective Model for the Multilevel Supply Chain of Blood Products with the Approach of Reducing the Rate of Contagion under the (COVID-19) Epidemic Outbreak Conditions

Impact of the COVID‐19 outbreak on blood supply in two large university hospitals

Research on the effectiveness and strategies of new media in promoting voluntary blood donation from a public health perspective in the post-pandemic era

Discussion on the recruitment strategy for apheresis platelet donors in Chongqing during a public health emergency*

Public opinion communication mechanism of public health emergencies in Weibo: take the COVID-19 epidemic as an example

Impact of the COVID-19 Pandemic on Blood Transfusion among Hospitalized Patients with Chronic Kidney Disease

Analysis of emergency Drug Approval System in China and the United States under Public Health emergencies and its enlightenment to China

Challenges to the System of Reserve Medical Supplies for Public Health Emergencies: Reflections on the Outbreak of the Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Epidemic in China.

Evaluation of China's public health system response to COVID-19

Platelet Pathogen Reduction Technology—Should We Stay or Should We Go...?